Načítá se...
Iron‐chelating agents for treating malaria
BACKGROUND: It is still unclear whether iron‐chelating agents, such as intravenous desferrioxamine (DFO) and oral deferiprone, given alone or added to standard antimalarial treatment would reduce malaria deaths. OBJECTIVES: To evaluate iron‐chelating agents alone or combined with standard antimalari...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2003
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6532667/ https://ncbi.nlm.nih.gov/pubmed/10796645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001474 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|